The Newest Biotech Spiker On My Watchlist

There's Still Time!

‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  The Newest Biotech Spiker On My Watchlist Hey,   Hey traders, it's Bryce here.   Last week's big biotech spike came from Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP).   The stock launched 370% on Friday, January 26. It was directly after the company announced positive data from its first human trial for a new cancer treatment.   There's a chart below with the news alerts included …  CRBP chart 1-day, 2-minute candles Source: StocksToTrade There were at least two dips during the day that offered solid profit opportunities.   And going into Monday, even my mentor Tim Sykes was looking for the next biotech spiker.   Sure enough, a former runner announced positive data from a preclinical test for a new treatment of GI diseases. The price spiked 180%.   And there's still a chance it pushes higher.   The market is on fire right now. And I've got a watchlist full of multi-day runners.   Monday's biotech spiker is at the top of my list. The Newest Biotech Setup Only the best plays, Bryce Tuohey, Editor, To The Moon Report P.S. Don't miss this week's biggest trade opportunity. We watch for the same pattern every single week at a very specific time. Here are all the details. Who Is Bryce Tuohey? The Perfect Pattern For Side Hustlers. How To Follow LIVE Stock Trading. Click Here to Unsubscribe   13809 Research Boulevard, Suite 500, Austin, TX 78750   This is for informational purposes only as StocksToTrade is not registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund.   StocksToTrade cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing.   StocksToTrade in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, StocksToTrade accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.   Copyright © StocksToTrade.com